Pharmaceutical companies by short interest

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

TG Therapeutics leads the 61 pharmaceutical companies ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.

Key facts

Companies ranked
61
First
TG Therapeutics19.0%
Median
5.47%
Combined market value
€4.61T
Countries
10

Market values as of .

All countries
All sectors
Pharmaceuticals
EUR
Clear filters
Pharmaceutical companies by short interest
#CompanyShort interest % ↓Market capPriceToday1 yearPrice, 30 daysCountry
1TG TherapeuticsTGTX · Health Care19.0%€9.1B€60.23 5.44% up 107% up United States
2Rhythm PharmaceuticalsRYTM · Health Care16.8%€7.5B€108.43 2.08% up 13% up United States
3Dianthus TherapeuticsDNTH · Health Care16.5%€4.3B€76.50 3.45% down 113% up United States
4Protagonist TherapeuticsPTGX · Health Care15.7%€7.6B€115.83 2.00% up 46% up United States
5Praxis Precision MedicinesPRAX · Health Care15.1%€7.8B€278.00 0.04% up 61% up United States
6CytokineticsCYTK · Health Care12.9%€6.5B€46.75 0.64% down 20% down United States
7Ionis PharmaceuticalsIONS · Health Care12.7%€4.2B€24.95 1.59% up 64% down United States
8Ligand PharmaceuticalsLGND · Health Care12.3%€5.4B€272.09 1.67% up 43% up United States
9Spyre TherapeuticsSYRE · Health Care12.2%€8.8B€92.42 8.15% up 286% up United States
10AlkermesALKS · Health Care11.7%€7.2B€42.68 3.08% up 58% up Ireland
11Edgewise TherapeuticsEWTX · Health Care11.6%€4.1B€37.68 1.59% down 88% up United States
12BridgeBio PharmaBBIO · Health Care10.7%€13.8B€71.06 1.58% up 17% up United States
13ErascaERAS · Health Care10.6%€4.4B€12.53 0.94% down 403% up United States
14Cogent BiosciencesCOGT · Health Care10.0%€4.4B€25.33 0.14% down 20% down United States
15Mirum PharmaceuticalsMIRM · Health Care9.99%€5.5B€84.25 0.59% up 31% up United States
16Travere TherapeuticsTVTX · Health Care9.96%€4.4B€45.76 1.68% down 44% up United States
17Oruka TherapeuticsORKA · Health Care9.53%€5.9B€87.21 0.60% down 241% up United States
18PTC TherapeuticsPTCT · Health Care9.31%€4.6B€54.86 0.22% down 20% down United States
19Madrigal PharmaceuticalsMDGL · Health Care9.20%€8.4B€362.61 5.67% down 24% down United States
20Jazz PharmaceuticalsJAZZ · Health Care9.03%€14.5B€225.69 2.93% up 37% up Ireland
21Corcept TherapeuticsCORT · Health Care8.34%€6.8B€61.75 3.25% down 8% down United States
22Arrowhead PharmaceuticalsARWR · Health Care8.19%€5.6B€39.27 0.28% up 10% up United States
23VeradermicsMANE · Health Care8.03%€4.8B€113.73 0.62% down 233% up United States
24BioMarin PharmaceuticalBMRN · Health Care7.29%€10.8B€55.96 4.99% up 11% up United States
25Definium TherapeuticsDFTX · Health Care7.02%€3.6B€26.53 0.88% down 169% up United States
26Elanco Animal HealthELAN · Health Care6.59%€12.2B€24.32 3.29% up 20% up United States
27InsmedINSM · Health Care6.42%€23.9B€109.13 1.69% down 40% down United States
28Roivant SciencesROIV · Health Care6.28%€25.6B€35.28 0.05% up 90% up United Kingdom
29Axsome TherapeuticsAXSM · Health Care6.20%€6.4B€122.06 1.43% down 7% down United States
30Legend BiotechLEGN · Health Care6.13%€2.9B€14.80 0.87% up 42% down United States
31Kiniksa Pharmaceuticals InternationalKNSA · Health Care5.47%€6.8B€86.58 0.06% down 126% up United Kingdom
32Summit TherapeuticsSMMT · Health Care5.28%€7.6B€9.56 1.59% down 36% down United States
33ABIVAXABVX · Health Care4.70%€6.7B€76.36 2.11% up 27% down France
34Ascendis PharmaASND · Health Care4.57%€16.2B€246.24 0.32% down 28% up Denmark
35United TherapeuticsUTHR · Health Care4.31%€22.4B€525.90 1.16% down 23% up United States
36ZoetisZTS · Health Care4.12%€31.7B€77.95 2.50% up 29% down United States
37Alnylam PharmaceuticalsALNY · Health Care4.08%€18.2B€136.09 4.54% down 66% down United States
38Belite BioBLTE · Health Care3.40%€5.8B€142.31 0.94% down 31% up United States
39Amneal PharmaceuticalsAMRX · Health Care3.27%€6.9B€19.93 3.60% up 83% up United States
40ViatrisVTRS · Health Care3.07%€21.2B€18.47 0.83% down 96% up United States
41Dr. Reddy's LaboratoriesRDY · Health Care3.03%€11.4B€13.65 1.28% up 5% up India
42Teva Pharmaceutical IndustriesTEVA · Health Care2.38%€44.9B€38.47 0.92% down 74% up Israel
43PfizerPFE · Health Care2.36%€145.7B€25.56 1.44% down 14% up United States
44Bristol-Myers SquibbBMY · Health Care2.29%€110.9B€54.25 2.92% down 34% up United States
45Royalty PharmaRPRX · Health Care2.27%€36B€62.55 0.01% down 78% up United States
46Regeneron PharmaceuticalsREGN · Health Care2.14%€89.1B€861.28 1.28% down 36% up United States
47Vertex PharmaceuticalsVRTX · Health Care1.90%€123.9B€488.65 0.42% up 27% up United States
48GenmabGMAB · Health Care1.57%€28.6B€46.43 1.91% down 70% up Denmark
49BeOne MedicinesONC · Health Care1.40%€42B€367.64 2.34% down 17% up Switzerland
50Abbott LaboratoriesABT · Health Care1.10%€164.8B€95.17 0.22% down 17% down United States
51Merck & CoMRK · Health Care1.08%€309.4B€125.50 3.90% down 51% up United States
52AbbVieABBV · Health Care0.89%€460.5B€260.53 2.33% down 26% up United States
53GrifolsGRFS · Health Care0.88%€5.3B€7.72 1.85% down 1% up Spain
54Novo NordiskNVO · Health Care0.87%€158.3B€35.92 3.12% down 17% down Denmark
55Eli LillyLLY · Health Care0.81%€1.12T€1,259.55 2.32% down 35% up United States
56GSKGSK · Health Care0.81%€88.7B€44.25 1.34% down 6% up United Kingdom
57Johnson & JohnsonJNJ · Health Care0.71%€598B€248.40 2.15% down 38% up United States
58SanofiSNY · Health Care0.51%€103.1B€42.92 0.86% down 4% down France
59NovartisNVS · Health Care0.24%€267B€141.38 2.46% down 25% up Switzerland
60AstraZenecaAZN · Health Care0.20%€252.5B€162.83 1.93% down 2% up United Kingdom
61Takeda PharmaceuticalTAK · Health Care0.10%€61.9B€19.37 1.71% down 54% up Japan

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 0.9109 EUR).

Questions and answers

Which pharmaceutical companies rank first by short interest?

TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceutical companies ranked by short interest as of the 30 Oct 2026 settlement date.

How many pharmaceutical companies are in this ranking?

61 are ranked by short interest.

What are these pharmaceutical companies worth together?

The 61 pharmaceutical companies ranked by short interest have a combined market value of €4.61T as of the 30 Oct 2026 settlement date.

What does ranking by short interest measure?

Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.

Cite this page

Funkfolio, “Pharmaceutical companies by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest

Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.